Point-of-care tools to support optometric care provision to people with age-related macular degeneration: A randomised, placebo-controlled trial

SA Gocuk; AM McKendrick; LE Downie

Journal article

Point-of-care tools to support optometric care provision to people with age-related macular degeneration: A randomised, placebo-controlled trial

SA Gocuk, AM McKendrick, LE Downie

Ophthalmic and Physiological Optics | WILEY | Published : 2022

DOI: 10.1111/opo.12970

Download PDF

Abstract

Purpose: Age-related macular degeneration (AMD) is a leading cause of vision impairment. This randomised placebo-controlled trial investigated whether point-of-care tools can improve optometrists' AMD knowledge and/or care provision. Methods: Australian optometrists (n = 31) completed a demographics survey and theoretical AMD case study multiple-choice questions (MCQs) to assess their confidence in AMD care provision and AMD knowledge. Participants were then randomly assigned to one of three point-of-care tools (online ‘Classification of Age-related macular degeneration and Risk Assessment Tool’ (CARAT), paper CARAT, or ‘placebo’) to use when providing care to their subsequent 5–10 AMD patie..

View full abstract

University of Melbourne Researchers

Allison McKendrick Author

Laura Downie Author

Sena Gocuk Author

Related Projects (1)

AN INTEGRATED APPROACH TO IMPROVING THE PRIMARY CLINICAL CARE OF PATIENTS WITH EARLY STAGES OF AGE-RELATED MACULAR DEGENERATION

Age-related macular degeneration (AMD) is a leading cause of blindness in Australia. Preventing progression to late AMD is the most valuable..

Grants

Awarded by University of Melbourne

Funding Acknowledgements

This project was partially funded by a 2015 Macular Disease Foundation Australia Blackmores research grant (Principal Investigator: Downie), and a NHMRC Translating Research Into Practice (TRIP) Fellowship (APP1091833 Downie).